Mounjaro acts like the GLP-1 hormone, but also like another hormone called glucose-dependent insulinotropic polypeptide (GIP)
Molinelli E, Morresi C, Dragonetti ML, De Simoni E, Candelora M, Marasca S, et al
In the present study, we examined the effect of once-weekly semaglutide 2.4 mg on kidney outcomes in the SELECT trial
While these medications can be a valuable and effective tool for weight loss when discussed with a doctor, many experts have emphasized the importance education plays in ensuring patients are still getting nutrients they need amid the lower appetite and decrease in food intake
Future research related to GLP-1Ra and bone health Observational studies with long-term follow-up of bone health for patients under GLP-1Ra are necessary because fracture risk remains to be determined
Retatrutide can be used as one component of this kind of multi axis study design where receptor activation is evaluated alongside transcriptional programs, metabolic flux proxies, and cellular energy handling signatures, enabling laboratories to build more complete maps of pathway convergence and divergence under matched experimental conditions
